Midatech Pharma Plc (MTP)

0.76
0.00 0.47
NASDAQ : Health Technology
Prev Close 0.77
Open 0.80
Day Low/High 0.76 / 0.80
52 Wk Low/High 0.75 / 10.90
Volume 12.82K
Avg Volume 148.90K
Exchange NASDAQ
Shares Outstanding 23.50M
Market Cap 21.02M
EPS -5.90
Div & Yield N.A. (N.A)

Latest News

Midatech Pharma Plc: Trading Update

Midatech Pharma Plc: Trading Update

Midatech Pharma PLC: Trading Update

Midatech Pharma PLC: Trading Update

Result Of Annual General Meeting

Result Of Annual General Meeting

AGM Statement And Update On Trading

AGM Statement And Update On Trading

Midatech Pharma Announces Positive Pharmacokinetic Data With Q-Octreotide

Midatech Pharma Announces Positive Pharmacokinetic Data With Q-Octreotide

Release profile of Midatech's Q-Octreotide compared favourably with the reference product and current market leader

Midatech Achieves Positive Dosing Data For OpsiSporin Uveitis Programme

Midatech Achieves Positive Dosing Data For OpsiSporin Uveitis Programme

Programme is delivering on track for an IND in H2 2017

Midatech's Commercial Launch Of Zuplenz® (Ondansetron) Oral Soluble Film To Prevent Post-Operative, Chemotherapy And Radiation-Induced Nausea And Vomiting In US

Midatech's Commercial Launch Of Zuplenz® (Ondansetron) Oral Soluble Film To Prevent Post-Operative, Chemotherapy And Radiation-Induced Nausea And Vomiting In US

Midatech further expands its commercial footprint in US, supporting the Zuplenz® launch

Midatech Pharma Recognises International Rare Disease Day 2016

Midatech Pharma Recognises International Rare Disease Day 2016

Dosing Has Commenced With MTX110 for DIPG on a Named Patient Basis

Midatech Completes Acquisition Of Zuplenz®

Midatech Completes Acquisition Of Zuplenz®

Further Product Acquisition Bolsters Marketed Oncology Portfolio